Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Filings indexed 212 across all filing types
Latest filing 2025-05-19 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-05-19 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an Investor Presentation dated May 19, 2025, from Innova Captab Limited. It is addressed to stock exchanges and announces an upcoming earnings call and includes detailed slides on company overview, business areas, manufacturing facilities, milestones, and quarterly and yearly financial performance highlights. The content is typical of an investor presentation focusing on financials, strategy, and market position. It is not a full annual or quarterly report, audit report, or earnings release but a presentation prepared for analysts and institutional investors. The document length is substantial (15,000 characters) and contains detailed financial and operational data, consistent with an Investor Presentation (IP).
2025-05-19 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the audited financial results for the quarter and financial year ended March 31, 2025. It contains detailed financial performance data including revenue, EBITDA, and profit after tax for Q4 FY25 and FY25 compared to prior periods. The document includes management commentary on the results and operational highlights. It is not a full annual report (10-K) but rather a formal earnings announcement with key financial highlights and narrative commentary. The document is about 7,650 characters, which is consistent with a detailed earnings release rather than a brief announcement or a full annual report. Therefore, the document fits the definition of an Earnings Release (ER). FY 2025
2025-05-19 English
Address Change
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing a change in the registered office address of the company. It references compliance with SEBI Listing Regulations, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of a corporate administrative change (office relocation within the same city) approved by the Board of Directors. There are no financial statements, audit information, earnings data, or detailed reports included. The document is short (2031 characters) and serves as a regulatory disclosure rather than a report or detailed filing. This fits the category of a Regulatory Filing (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-19 English
Change in Auditors
Regulatory Filings
2025-05-19 English
Outcome of Board Meeting
Regulatory Filings
2025-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.